Global Chemotherapy Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Mitotic Inhibitors, Alkylating Agents, Antimetabolites, Topoisomerase Inhibitors and Antitumor Antibiotic), By Indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Lymphoma, Leukemia, and Ovarian Cancer), By Route of Drug Administration (Intravenous, Oral, Subcutaneous, Intra-Muscular, Intravesicular, Topical, Intraperitoneal, and Intraventricular/Intrathecal), By End-User (Specialty Centers and Hospitals & Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Industry: Healthcare
RELEASE DATE Mar 2024
REPORT ID SI4041
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Drug Class
      2. Market Attractiveness Analysis By Indication
      3. Market Attractiveness Analysis By Route of Drug Administration
      4. Market Attractiveness Analysis By End-User
      5. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Growing prevalence of cancer
      2. Conducting research and training on cancer by government organizations
      3. Increased Healthcare Infrastructure Cost
    3. Restraints
      1. High cost associated with R&D of chemotherapeutic drugs and cancer treatments
      2. Stringent regulatory requirements and patent expiration of anti-cancer drugs
    4. Opportunities
      1.  Increased number of R&D activities
    5. Challenges
      1. Side-effects associated with the use of chemotherapeutic drugs and occurrence of drug resistance
  6. Global Chemotherapy Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. Mitotic Inhibitors
    3. Alkylating Agents
    4. Antimetabolites
    5. Topoisomerase Inhibitors
    6. Antitumor Antibiotic
  7. Global Chemotherapy Market Analysis and Projection, By Indication
    1. Segment Overview
    2. Breast Cancer
    3. Lung Cancer
    4. Colorectal Cancer
    5. Prostate Cancer
    6. Stomach Cancer
    7. Lymphoma
    8. Leukemia
    9. Ovarian Cancer
  8. Global Chemotherapy Market Analysis and Projection, By Route of Drug Administration
    1. Segment Overview
    2. Intravenous
    3. Oral
    4. Subcutaneous
    5. Intra-Muscular
    6. Intravesicular
    7. Topical
    8. Intraperitoneal
    9. Intraventricular/Intrathecal
  9. Global Chemotherapy Market Analysis and Projection, By End-User
    1. Segment Overview
    2. Specialty Centers
    3. Hospitals & Clinics
  10. Global Chemotherapy Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  11. Global Chemotherapy Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Chemotherapy Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  12. Company Profiles
    1. Pfizer Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Sanofi SA  
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Johnson & Johnson Services Inc.  
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   GlaxoSmithKline Plc.  
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Novartis AG  
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Eli Lilly & Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Merck & Co.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Teva Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Celgene Corporation
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Bayer AG  
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Bristol-Myers Squibb
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Boehringer Ingelheim
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Takeda Pharmaceutical Company Limited  
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Schering-Plough
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others  
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  2. Global Mitotic Inhibitors, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  3. Global Alkylating Agents, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  4. Global Antimetabolites, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  5. Global Topoisomerase Inhibitors, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  6. Global Antitumor Antibiotic, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  7. Global Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  8. Global Breast Cancer, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  9. Global Lung Cancer, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  10. Global Colorectal Cancer, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  11. Global Prostate Cancer, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  12. Global Stomach Cancer, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  13. Global Lymphoma, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  14. Global Leukemia, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  15. Global Ovarian Cancer, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  16. Global Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  17. Global Intravenous, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  18. Global Oral, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  19. Global Subcutaneous, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  20. Global Intra-Muscular, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  21. Global Intravesicular, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  22. Global Topical, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  23. Global Intraperitoneal, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  24. Global Intraventricular/Intrathecal, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  25. Global Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  26. Global Specialty Centers, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  27. Global Hospitals & Clinics, Chemotherapy Market, By Region, 2023-2033(USD Billion)
  28. North America Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  29. North America Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  30. North America Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  31. North America Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  32. U.S.  Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  33. U.S.  Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  34. U.S.  Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  35. U.S.  Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  36. Canada Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  37. Canada Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  38. Canada Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  39. Canada Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  40. Mexico Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  41. Mexico Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  42. Mexico Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  43. Mexico Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  44. Europe Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  45. Europe Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  46. Europe Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  47. Europe Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  48. Germany Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  49. Germany Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  50. Germany Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  51. Germany Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  52. France Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  53. France Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  54. France Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  55. France Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  56. U.K.  Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  57. U.K.  Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  58. U.K.  Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  59. U.K.  Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  60. Italy Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  61. Italy Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  62. Italy Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  63. Italy Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  64. Spain Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  65. Spain Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  66. Spain Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  67. Spain Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  68. Asia Pacific Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  69. Asia Pacific Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  70. Asia Pacific Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  71. Asia Pacific Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  72. Japan Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  73. Japan Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  74. Japan Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  75. Japan Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  76. China Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  77. China Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  78. China Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  79. China Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  80. India Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  81. India Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  82. India Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  83. India Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  84. South America Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  85. South America Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  86. South America Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  87. South America Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  88. Brazil Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  89. Brazil Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  90. Brazil Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  91. Brazil Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  92. The Middle East and Africa Chemotherapy Market, By Drug Class, 2023-2033(USD   Billion)
  93. The Middle East and Africa Chemotherapy Market, By Indication, 2023-2033(USD   Billion)
  94. The Middle East and Africa Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  95. The Middle East and Africa Chemotherapy Market, By End-User, 2023-2033(USD Billion)
  96. UAE Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  97. UAE Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  98. UAE Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  99. UAE Chemotherapy Market, By End-User, 2023-2033(USD Billion)  
  100. South Africa Chemotherapy Market, By Drug Class, 2023-2033(USD Billion)
  101. South Africa Chemotherapy Market, By Indication, 2023-2033(USD Billion)
  102. South Africa Chemotherapy Market, By Route of Drug Administration, 2023-2033(USD Billion)
  103. South Africa Chemotherapy Market, By End-User, 2023-2033(USD Billion)

List of Figures 

  1. Global Chemotherapy Market Segmentation
  2. Chemotherapy Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Chemotherapy Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Chemotherapy Market
  20. Chemotherapy Market Segmentation, By Drug Class
  21. Chemotherapy Market For Mitotic Inhibitors, By Region, 2023-2033 ($ Billion)
  22.  Chemotherapy Market For Alkylating Agents, By Region, 2023-2033 ($ Billion)
  23. Chemotherapy Market For Antimetabolites, By Region, 2023-2033 ($ Billion)
  24. Chemotherapy Market For Topoisomerase Inhibitors, By Region, 2023-2033 ($ Billion)
  25. Chemotherapy Market For Antitumor Antibiotic, By Region, 2023-2033 ($ Billion)
  26.  Chemotherapy Market Segmentation, By Indication
  27.  Chemotherapy Market For Breast Cancer, By Region, 2023-2033 ($ Billion)
  28.  Chemotherapy Market For Lung Cancer, By Region, 2023-2033 ($ Billion)
  29. Chemotherapy Market For Colorectal Cancer, By Region, 2023-2033 ($ Billion)
  30. Chemotherapy Market For Prostate Cancer, By Region, 2023-2033 ($ Billion)
  31. Chemotherapy Market For Stomach Cancer, By Region, 2023-2033 ($ Billion)
  32. Chemotherapy Market For Lymphoma, By Region, 2023-2033 ($ Billion)
  33. Chemotherapy Market For Leukemia, By Region, 2023-2033 ($ Billion)
  34. Chemotherapy Market For Ovarian Cancer, By Region, 2023-2033 ($ Billion)
  35. Chemotherapy Market Segmentation, By Route of Drug Administration
  36. Chemotherapy Market For Intravenous, By Region, 2023-2033 ($ Billion)
  37. Chemotherapy Market For Oral, By Region, 2023-2033 ($ Billion)
  38. Chemotherapy Market For Subcutaneous, By Region, 2023-2033 ($ Billion)
  39. Chemotherapy Market For Intra-Muscular, By Region, 2023-2033 ($ Billion)
  40. Chemotherapy Market For Intravesicular, By Region, 2023-2033 ($ Billion)
  41. Chemotherapy Market For Topical, By Region, 2023-2033 ($ Billion)
  42. Chemotherapy Market For Intraperitoneal, By Region, 2023-2033 ($ Billion)
  43. Chemotherapy Market For Intraventricular/Intrathecal, By Region, 2023-2033 ($ Billion)
  44. Chemotherapy Market Segmentation, By End-User
  45. Chemotherapy Market For Specialty Centers, By Region, 2023-2033 ($ Billion)
  46. Chemotherapy Market For Hospitals & Clinics, By Region, 2023-2033 ($ Billion)
  47. Pfizer Inc.: Net Sales, 2023-2033 ($ Billion)
  48. Pfizer Inc.: Revenue Share, By Segment, 2023 (%)
  49. Pfizer Inc.: Revenue Share, By Region, 2023 (%)
  50. Sanofi SA: Net Sales, 2023-2033 ($ Billion)
  51. Sanofi SA: Revenue Share, By Segment, 2023 (%)
  52. Sanofi SA: Revenue Share, By Region, 2023 (%)
  53. Johnson & Johnson Services Inc.: Net Sales, 2023-2033 ($ Billion)
  54. Johnson & Johnson Services Inc.: Revenue Share, By Segment, 2023 (%)
  55. Johnson & Johnson Services Inc.: Revenue Share, By Region, 2023 (%)
  56. GlaxoSmithKline Plc.: Net Sales, 2023-2033 ($ Billion)
  57. GlaxoSmithKline Plc.: Revenue Share, By Segment, 2023 (%)
  58. GlaxoSmithKline Plc.: Revenue Share, By Region, 2023 (%)
  59. Novartis AG: Net Sales, 2023-2033 ($ Billion)
  60. Novartis AG: Revenue Share, By Segment, 2023 (%)
  61. Novartis AG: Revenue Share, By Region, 2023 (%)
  62. Eli Lilly & Company: Net Sales, 2023-2033 ($ Billion)
  63. Eli Lilly & Company: Revenue Share, By Segment, 2023 (%)
  64. Eli Lilly & Company: Revenue Share, By Region, 2023 (%)
  65. Merck & Co.: Net Sales, 2023-2033 ($ Billion)
  66. Merck & Co.: Revenue Share, By Segment, 2023 (%)
  67. Merck & Co.: Revenue Share, By Region, 2023 (%)
  68. Teva Pharmaceuticals: Net Sales, 2023-2033 ($ Billion)
  69. Teva Pharmaceuticals: Revenue Share, By Segment, 2023 (%)
  70. Teva Pharmaceuticals: Revenue Share, By Region, 2023 (%)
  71. Celgene Corporation.: Net Sales, 2023-2033 ($ Billion)
  72. Celgene Corporation.: Revenue Share, By Segment, 2023 (%)
  73. Celgene Corporation.: Revenue Share, By Region, 2023 (%)
  74. Bayer AG: Net Sales, 2023-2033 ($ Billion)
  75. Bayer AG: Revenue Share, By Segment, 2023 (%)
  76. Bayer AG: Revenue Share, By Region, 2023 (%)
  77. Bristol-Myers Squibb: Net Sales, 2023-2033 ($ Billion)
  78. Bristol-Myers Squibb: Revenue Share, By Segment, 2023 (%)
  79. Bristol-Myers Squibb: Revenue Share, By Region, 2023 (%)
  80. Boehringer Ingelheim: Net Sales, 2023-2033 ($ Billion)
  81. Boehringer Ingelheim: Revenue Share, By Segment, 2023 (%)
  82. Boehringer Ingelheim: Revenue Share, By Region, 2023 (%)
  83. Takeda Pharmaceutical Company Limited: Net Sales, 2023-2033 ($ Billion)
  84. Takeda Pharmaceutical Company Limited: Revenue Share, By Segment, 2023 (%)
  85. Takeda Pharmaceutical Company Limited: Revenue Share, By Region, 2023 (%)
  86. Schering-Plough: Net Sales, 2023-2033 ($ Billion)
  87. Schering-Plough: Revenue Share, By Segment, 2023 (%)
  88. Schering-Plough: Revenue Share, By Region, 2023 (%)
  89. Others: Net Sales, 2023-2033 ($ Billion)
  90. Others: Revenue Share, By Segment, 2023 (%)
  91. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:110
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:6.54%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies